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Abstract
!
The essential oils have started to be recognized for their potential
antimicrobial role only in recent years. Clinical experience
showed that the efficacy of antimicrobial agents depends not on-
ly on their direct effect on a given microorganism but also on the
functional activity of the host immune system. Since data on the
effects of essential oils on the innate immune system are scanty
and fragmentary, the aim of this study was to evaluate the influ-
ence of thyme (red) essential oil (EO), at subinhibitory/inhibitory
concentrations, on intracellular killing activity by human
polymorphonuclear granulocytes (PMNs) against Candida albi-
cans. In order to provide a frame of reference for the activity of
this EO, its in vitro killing activity in the absence of PMNswas also
evaluated.
Results showed that EO at subminimal inhibitory (subMIC)/min-
imal inhibitory (MIC) concentrations significantly enhanced in-
tracellular killing of C. albicans in comparison with EO-free con-
trols and was comparable to the positive control (fluconazole). In
in vitro killing assays without PMNs, we observed progressive
growth of the yeast cells in the presence of EO subMIC/MIC con-
centrations. A positive antifungal interaction with phagocytes
could explain why this EO, which appeared to be only fungistatic
in time-kill assays, had efficacy in killing yeast cells once incu-
bated with PMNs.
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The increasing recognition and importance of fungal infections,
the difficulties encountered in their treatment, and the increase
in resistance to antifungal agents have stimulated the search for
new therapeutic alternatives [1]. The essential oils and products
of plant secondary metabolism had a wide application in folk
medicine, fragrance industries, as well as food flavoring and pres-
ervation, but only in recent years they have started to be recog-
nized for their potential antimicrobial role [2–4]. The literature
reports evidence suggesting that a larger number of plants and
their constituents could show beneficial therapeutic effects, in-
cluding antioxidant, anti-inflammatory, and immunomodulatory
activity, which still need to be further investigated [5–9]. In par-
ticular, data on the effects of essential oils on the innate immunesystem are scanty and fragmentary. As PMNs play a pivotal role
against invading microbial pathogens, enhanced PMN activity
under the essential oils influence may contribute to their anti-in-
fective properties [10,11].
The essential oil from Thymus vulgaris L. is widely used in folk
medicine for the treatment of a variety of diseases since it pos-
sesses numerous biological properties including antibacterial,
antifungal, and antioxidant activity [1,3,12–17].
In this paper, we report the interaction of thyme (red) EO with
human PMNs, focusing on intracellular killing of Candida albi-
cans. As a positive control, we used fluconazole, one of the most
common antifungal drugs in candidiasis management, known to
enhance the fungicidal activity of PMNs [10]. Moreover, in order
to provide a frame of reference for the activity of this EO, its in
vitro killing in the absence of PMNs was also evaluated.
EO MICs for C. albicanswere 0.03 and 0.5% v/v, while fluconazole
MICs were 0.5 and 8 µg/mL with inocula of 103 and 106 ufc/mL,
respectively. In the absence of PMNs, the EO activity was only
fungistatic at all concentrations tested, causing slight reductions
(i.e., ≤ 3 log10) in the starting inoculum, as shown in l" Fig. 1. At
subMIC/MIC concentrations, killing activity was not sustained
over time because yeast cell growth was seen at 24 h.
Clinical experience showed that the efficacy of antimicrobial
agents depends not only on their direct effect on a given micro-
organism but also on the functional activity of the immune sys-
tem [10,11,18]. Results on effects upon the PMNs intracellular
killing showed that EO and fluconazole had similar candidacidal
activity (l" Table 1). EO at 1 ×MIC significantly increased the in-
tracellular killing by phagocytes, with percentages that ranged
from 50 to 73%, in comparison with controls (EO-free), ranging
from 33 to 50% (l" Table 1; p < 0.01). In the presence of 1 ×MIC
fluconazole, intracellular yeasts were killed at 51–69–75%
(p < 0.01).
A similar picture was detected even at lower levels of EO (1/
2 ×MIC), where killing values (44–57–69%) were significantly
higher than those of control systems (33–47–50%; p < 0.05) and
overlappedwith those observed in presence of 1/2 ×MIC flucona-
zole (42–58–63%).
The mechanism of such enhancement is still unknown; despite
the fact that this EO displayed only a fungistatic action in the ab-
sence of PMNs, it showed efficacy in killing yeasts once simulta-
neously incubated with PMNs, suggesting a positive antifungal
interaction with phagocytes, as previously observed with other
antifungal agents [10,19].
EO direct damage to the yeast cell may be, at least in part, respon-
sible for changes that make the yeasts more susceptible to PMN
lytic mechanisms. The EO used in this study is mainly composed
of thymol, ρ-cymene, limonene, α-pinene, carvacrol, and γ-terpi-
nene, at different percentages [3], but it is not clear which of the
active ingredients accounted for the observed effect on yeast kill-
ing.
Recent literature data reported that thymol and carvacrol exhibit
fungicidal activity in a dose-dependent fashion against yeasts, re-
sulting from direct damage to cell membranes [20]. Since essen-
tial oils are phytocomplexes containing numerous molecules,
their bioactivity could be the result of a synergism of all major
and minor components [21,22]. In fact, antifungal susceptibility
testing on thymol and carvacrol showed that these components
exhibitedMIC values higher (0.06% v/v) than those obtainedwith
whole EO (0.03% v/v) against C. albicans (data not shown). Fur-
ther investigations are needed to confirm these findings.Tullio V et al. Positive Interaction of… Planta Med 2012; 78: 1633–1635
Fig. 1 Effect of thyme (red) essential oil on the in
vitro killing of Candida albicans. C. albicans (106 cfu/
mL) was incubated with the EO at 4% v/v (8 ×MIC),
2% v/v (4 ×MIC), 1% v/v (2 ×MIC), 0.5% v/v
(1 ×MIC), 0.25% v/v (1/2 ×MIC), 0.125% v/v (1/
4 ×MIC), and 0.06% v/v (1/8 ×MIC).
Table 1 Effect of thyme (red) essential oil and fluconazole at 1/2 ×MIC/1 ×MIC on intracellular killing of C. albicans by human PMNs.
Mean SI ± SEM (% of initial fungal population killed by PMNs in absence or presence of fluconazole or EO)
Time
(min)
Controls 1/2 ×MIC fluconazole
(4 µg/mL)
1 ×MIC fluconazole
(8 µg/mL)
1/2 ×MIC thyme (red)
EO (0.25% v/v)
1 ×MIC thyme (red) EO
(0.5% v/v)
30 1.67 ± 0.03 (33%) 1.58b ± 0.08 (42%) 1.49a ± 0.07 (51%) 1.56b ± 0.07 (44%) 1.50a ± 0.01 (50%)
60 1.53 ± 0.02 (47%) 1.42b ± 0.08 (58%) 1.31a ± 0.06 (69%) 1.43b ± 0.11 (57%) 1.36a ± 0.04 (64%)
90 1.50 ± 0.03 (50%) 1.37b ± 0.17 (63%) 1.25a ± 0.06 (75%) 1.31b ± 0.07 (69%) 1.27a ± 0.02 (73%)
a Significantly different from the controls (p < 0.01); b significantly different from the controls (p < 0.05)
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A clinical C. albicans strain was isolated from blood, identified by
conventional methods and subcultured on Sabouraud dextrose
agar (SAB). Yeasts cultures consisted entirely of blastoconidia
and had a slight tendency to differentiate into pseudohyphae
during the course of the experiments [10].
The thyme (red) EO commercially obtained from Azienda Agrico-
la Aboca was the same batch used and characterized by GC‑FID
analyses in a previous study [3]. Its major constituents were thy-
mol (26.5%), ρ-cymene (16.2%), limonene (13.2%), α-pinene
(13.2%), carvacrol (7.8%), and γ-terpinene (4%).
Antifungal susceptibility testing was based on the CLSI M27-A3
[23] method, with some modifications; the final EO concentra-
tions ranging from 1 to 0.0019% (v/v). EO and fluconazole (Sig-
ma-Aldrich; purity ≥ 98% by HPLC) MIC values for C. albicans
were determined with an inoculum of 103 cfu/mL and an inocu-
lum of 106 cfu/mL to perform tests with and without phagocytes.
In vitro killing was performed by using a 106 cfu/mL starting
yeast inoculum and EO at 4% v/v (8 ×MIC), 2% v/v (4 ×MIC), 1%
v/v (2 ×MIC), 0.5% v/v (1 ×MIC), 0.25% v/v (1/2 ×MIC), 0.125% v/
v (1/4 ×MIC), and 0.06% v/v (1/8 ×MIC). EO-free controls were in-
cluded. 500 µL aliquots were removed at 0, 30, 60, 90, 120,
180min, and 24 h, serially tenfold diluted and plated onto SAB
agar. After 24–48 h at 37°C, results were reported as log cfu/mL.
Fungicidal activity was defined as a 99.9% (≥ 3 log10) reduction in
viable cell counts as compared with the starting inoculum [11].Tullio V et al. Positive Interaction of… Planta Med 2012; 78: 1633–1635Human PMNs were separated from lithium heparinized venous
blood using Ficoll–Paque (Pharmacia S.p.A.) and adjusted to 106
cells/mL in RPMI1640 [11]. Viability, determined by trypan blue
exclusion, was greater than 95%.
The EO effect on the intracellular killing of C. albicans by PMNs
was investigated by incubating blastoconidia (106 cfu/mL) and
PMNs (106 cells/mL) for 30min to allow phagocytosis to proceed.
The PMN-yeast cell mixtures were centrifuged at 200 g for 5min
to remove extracellular blastoconidia. An aliquot of PMNs was
lysed by adding sterile water, and intracellular viable yeast count-
ing was performed (time zero). PMNs were incubated further
with 0.25% v/v and/or 0.5% v/v (1/2MIC and 1 ×MIC, respective-
ly) of EO and at time X (30, 60, 90min), the viable counts were
measured in the same way. EO-free controls were included. As
positive controls, 1/2 ×MIC (4 µg/mL) and 1 ×MIC (8 µg/mL) flu-
conazole were included. Killing values were expressed as a sur-
vival index (SI), which was calculated by adding the number of
surviving blastoconidia at time zero to the number of survivors
at time X and dividing by the number of survivors at time zero.
According to this formula, if fungal killing was 100% effective,
the SI would be 1 [10,11].
Results are expressed as the mean ± standard error of the mean
(SEM) of 10 separate experiments, each performed in quadrupli-
cate. Statistical evaluation of the differences between test and
control results was performed by Tukeyʼs test. In vitro killing
was compared using Studentʼs unpaired t-test.
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